Apr 1 |
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 6 |
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
|
Mar 5 |
Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...
|
Mar 1 |
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript
|
Mar 1 |
Q4 2023 Karyopharm Therapeutics Inc Earnings Call
|
Feb 29 |
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Karyopharm Therapeutics Inc. (KPTI) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Karyopharm Therapeutics Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 29 |
Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 29 |
Karyopharm Therapeutics GAAP EPS of -$0.36 misses by $0.07, revenue of $33.7M beats by $0.08M
|